The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals

Phase 4CompletedNCT00311974

Regional Hospital Holstebro16 enrolled

Overview

We, the investigators at Holstebro Hospital, want to test the hypothesis that dihydralazine leads to the activation of the sympathetic nervous system in healthy individuals.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Enrollment

Conditions

Healthy

Interventions

DihydralazineDRUG

Eligibility

Sex: MALEMin age: 18 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Men 2. Ages 18 to 40 years. 3. Body mass index less than or equal to 30 kg/m2 Exclusion Criteria: 1. History or clinical signs of heart, lung, kidney, or endocrine organ disease. 2. Abnormal biochemical screening of the blood regarding: B-hemoglobin, P-sodium, P-potassium, P-creatinine, P-albumin, P-bilirubin, P-alanine aminotransferase, P-alkaline phosphatase, P-cholesterol, and B-glucose. 3. Abnormal screening of the urine regarding: albumin and glucose 4. Malignant disease. 5. Known arterial hypertension or measured 24 hour blood pressure above 135 mmHg systolic or 85 mmHg diastolic. 6. Alcohol abuse. 7. Smoking. 8. Drug use or abuse. 9. Known intolerance or allergy to dihydralazine 10. Blood donation within 1 month of the start of the study.

Locations (1)

Department of Medical Research, Holstebro Hospital

Holstebro, Denmark

Outcomes

Primary Outcomes

Fractional sodium excretion

Heart rate

Blood pressure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.